Cardinal Health, Inc. (CAH) FY2025 Q1 P&L / Income Statement

Cardinal Health, Inc. (CAH) FY2025 Q1 P&L / Income Statement

Income statement for 2024-07-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

52,277,000,000 US dollars

Cost of Goods and Services Sold

50,375,000,000 US dollars

Gross margin

1,902,000,000 US dollars

Operating costs, net of other operating income (calculated)

1,334,000,000 US dollars

Operating earnings/(loss)

568,000,000 US dollars

Other income (expense), net (calculated)

negative 27,000,000 US dollars

Earnings/(loss) before income taxes

541,000,000 US dollars

Provision for/(benefit from) income taxes

124,000,000 US dollars

Net earnings/(loss)

417,000,000 US dollars

UNITED STATES

51,891,000,000 US dollars

Non-US

408,000,000 US dollars

Distribution, selling, general and administrative expenses

1,277,000,000 US dollars

Restructuring and employee severance

24,000,000 US dollars

Amortization and other acquisition-related costs

74,000,000 US dollars

Impairments and (gain)/loss on disposal of assets, net

negative 1,000,000 US dollars

Litigation (recoveries)/charges, net

negative 40,000,000 US dollars

Revenue before reconciliation (calculated)

52,299,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Components above reported revenue (calculated)

negative 22,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to Cardinal Health, Inc.: $416.00 M; to noncontrolling interests: $1.00 M.